Mesoblast Ltd Dividends
The next dividend date for Mesoblast Ltd has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Mesoblast Ltd (MESO)
More About Mesoblast Ltd
Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company's proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. It offers Remestemcel-L, which is in Phase III clinical trials for the treatment of systemic inflammatory diseases, including steroid refractory acute graft versus host disease and biologic refractory inflammatory bowel disease, as well as ulcerative colitis and Crohn's disease; and Remestemcel-L, which is in Phase III clinical trials to treat chronic heart failure and chronic low back pain due to degenerative disc disease. The company is also developing MPC-300-IV to treat biologic refractory rheumatoid arthritis diabetic nephropathy. It has strategic partnerships with Tasly Pharmaceutical Group to offer MPC-150-IM for the treatment or prevention of chronic heart failure; MPC-25-IC for the treatment or prevention of acute myocardial infarction; and Ryoncil for the treatment of pediatric SR-aGVHD; JCR Pharmaceuticals Co. Ltd. to treat wound healing in patients with epidermolysis bullosa and for the treatment of neonatal hypoxic ischemic encephalopathy; and Grünenthal to develops and commercializes cell therapy for the treatment of chronic low back pain. The company was incorporated in 2004 and is headquartered in Melbourne, Australia.
Owning Mesoblast Ltd Stock on the Dividend Date
If you own Mesoblast Ltd stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Mesoblast Ltd stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Mesoblast Ltd stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Mesoblast Ltd stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Mesoblast Ltd dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Mesoblast Ltd Dividends
You can contact us any time if you would like to ask questions about Mesoblast Ltd dividends or anything else related to the stock market.